Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity.
Cellular signalling·2014
Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2.
Journal of clinical pharmacology·2011
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist.
The Journal of pharmacology and experimental therapeutics·2010
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
British journal of pharmacology·2010
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP).
Clinical pharmacology and therapeutics·2010
AneuGuidederived metal coverage ratio and pore density in Pipeline embolization devices: validation against VasoCT and association with aneurysm occlusion.
Quantitative imaging in medicine and surgery·2026
Synergistic Surface and Interface Regulation of Ultralow-Pt-Loading Cathodes for Low-Alkalinity AEMWEs.
Journal of the American Chemical Society·2026
Droplet-driven self-powered Pb2 + extraction from industrial wastewater.
Journal of hazardous materials·2026
Steering pH-Dependent Pathways on Unconventional Phase Alloy Nanostructures for Universal Nitrate Electroreduction.
Advanced materials (Deerfield Beach, Fla.)·2026
Solvation-programmed hybrid interphase enables durable aqueous zinc-metal batteries.
Journal of colloid and interface science·2026